Myomo, Inc. (MYO)
$1.24-3.88%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $48M
- Beta
- 1.58
- P/E (TTM)
- -3.64
- Short % float
- 3.03%
- Days to cover
- 2.6
- SI change
- -10.9%
- 1W
- -14.48%
- 1M
- +0.00%
- vs SPY 1W
- -13.50%
- vs SPY 1M
- -1.86%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 28
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-85.2%
REV YoY-
ROE-142.0%
EPS YoY-
ROA-41.0%
GROSS68
OP-27
NET-34
[VALUATION]
P/E TTM-3.64
P/E FWD-
SECTOR PE20.48
INDUSTRY PE22.31
P/B9.08
P/FCF-
EV/EBITDA-5.72
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E344.47
ALTMAN Z-
CURR RATIO2.31
ND/EBITDA-
BETA1.58
Company news
FAQ
- What is LOPJLB’s current signal on MYO?
- LOPJLB’s latest quantitative signal on Myomo, Inc. (MYO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MYO in?
- Myomo, Inc. (MYO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Myomo, Inc. (MYO) do?
- Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their abili…